PMDA drug package insert
ムヒのこどもかぜ顆粒ｂ
PMDA OTC drug · 株式会社 池田模範堂 · package insert Jul 21, 2026
Key facts
| Brand names | ムヒのこどもかぜ顆粒ｂ |
|---|---|
| Companies | 製造販売元／テイカ製薬株式会社,販売会社／株式会社 池田模範堂 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | かぜ薬（内用） |
| Package insert date | Jul 21, 2026 |
| PMDA document key | 470004_K2303000025 |
| PMDA company code | 470004 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: